Tag:

Hims

Hims & Hers stock surges on potential Novo Nordisk deal

09 Mar 2026-15:28
Novo Nordisk, Hims to sell obesity drugs together

Danish drugmaker Novo Nordisk plans to sell its obesity treatments through the platform of Hims & Hers Health, ending a dispute between the two firms that recently escalated into a legal battle.

07 Mar 2026-09:31
Hims weight-loss pill push triggers FDA backlash

Hims & Hers Health’s attempt to launch a low-cost oral weight-loss pill has drawn swift regulatory and legal pushback, threatening the telehealth company’s next major growth strategy and intensifying scrutiny of drug compounders.

19 Feb 2026-15:30
Novo Nordisk shares jump after Hims drops weight-loss pill

Novo Nordisk shares rose after telehealth company Hims & Hers abandoned plans to launch a low-cost weight-loss pill based on semaglutide, following legal and regulatory pressure.

09 Feb 2026-12:10
Novo to sue over HIMS' compounded Wegovy pill

05 Feb 2026-21:34
Pfizer and Arcadium Lithium rise premarket; Apple, Amazon and Netflix fall

07 Oct 2024-16:57